United Therapeutics (UTHR) Enterprise Value (2016 - 2025)
Historic Enterprise Value for United Therapeutics (UTHR) over the last 17 years, with Q3 2025 value amounting to -$2.8 billion.
- United Therapeutics' Enterprise Value rose 1680.14% to -$2.8 billion in Q3 2025 from the same period last year, while for Sep 2025 it was -$2.8 billion, marking a year-over-year increase of 1680.14%. This contributed to the annual value of -$3.3 billion for FY2024, which is 911.46% down from last year.
- Per United Therapeutics' latest filing, its Enterprise Value stood at -$2.8 billion for Q3 2025, which was up 1680.14% from -$3.0 billion recorded in Q2 2025.
- In the past 5 years, United Therapeutics' Enterprise Value ranged from a high of -$1.7 billion in Q1 2021 and a low of -$3.3 billion during Q3 2024
- In the last 5 years, United Therapeutics' Enterprise Value had a median value of -$2.8 billion in 2025 and averaged -$2.7 billion.
- Per our database at Business Quant, United Therapeutics' Enterprise Value crashed by 4702.96% in 2022 and then soared by 1680.14% in 2025.
- Quarter analysis of 5 years shows United Therapeutics' Enterprise Value stood at -$1.9 billion in 2021, then crashed by 47.03% to -$2.8 billion in 2022, then fell by 5.47% to -$3.0 billion in 2023, then dropped by 9.11% to -$3.3 billion in 2024, then rose by 15.29% to -$2.8 billion in 2025.
- Its Enterprise Value stands at -$2.8 billion for Q3 2025, versus -$3.0 billion for Q2 2025 and -$3.3 billion for Q1 2025.